Dyslipidemia in Type 2 Diabetes (0767-034)

Summary

The purpose of the study is to compare the lipid-altering effects of MK0767, glipizide, and pioglitazone after 12 weeks of treatment. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Timeline

Start

2003-07

Primary completion

2003-11

Completion

2003-11

Drugs

Indications